학술논문
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022–May 2023
Document Type
Article
Author
Plumb, I.D.; Briggs Hagen, M.; Wiegand, R.; James Gist, J.; Abedi, G.; Fleming-Dutra, K.E.; Dumyati, G.; Myers, C.; Harland, K.K.; Faine, B.; Mohr, N.M.; Krishnadasan, A.; Chea, N.; Lee, J.E.; Kellogg, M.; Edmundson, A.; Britton, A.; Wilson, L.E.; Lovett, S.A.; Ocampo, V.; Markus, T.M.; Smithline, H.A.; Hou, P.C.; Lee, L.C.; Mower, W.; Talan, D.A.; Rwamwejo, F.; Steele, M.T.; Lim, S.C.; Schrading, W.A.; Chinnock, B.; Beiser, D.G.; Haran, J.P.; Nandi, U.; Chipman, A.K.; LoVecchio, F.; Eucker, S.; Femling, J.; Fuller, M.; Rothman, R.E.; Curlin, M.E.
Source
In: Vaccine . (Vaccine, 11 April 2024, 42(10):2543-2552)
Subject
Language
English
ISSN
18732518
0264410X
0264410X